Ultralife
ULBI
31 hedge funds and large institutions have $20M invested in Ultralife in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 2 closing their positions.
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.8% less ownership
Funds ownership: 27.89% → 27.09% (-0.8%)
3% less funds holding
Funds holding: 32 → 31 (-1)
17% less capital invested
Capital invested by funds: $24.2M → $20M (-$4.14M)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $60K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$127K |
| 2 |
VWA
Visionary Wealth Advisors
O'fallon,
Illinois
|
+$58.2K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$26.6K |
| 4 |
AW
ACG Wealth
Atlanta,
Georgia
|
+$4.92K |
| 5 |
BlackRock
New York
|
+$2.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$473K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$98.5K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$65.3K |
| 4 |
Two Sigma Advisers
New York
|
-$56K |
| 5 |
Renaissance Technologies
New York
|
-$53K |
ULBI Hedge Fund Activity: Q2 2022 in Review
31 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Ultralife (ULBI) for Q2 2022, worth a combined $20M — down 17% from $24.2M a quarter earlier.
Fund positioning in ULBI was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 12 trimmed.
The largest buyer was Janney Montgomery Scott, adding an estimated $127K. The largest seller was Morgan Stanley, cutting an estimated $473K.
- 31 institutional investors held Ultralife (ULBI) as of Q2 2022, down from 32 in Q1 2022.
- Funds reported $20M of Ultralife stock for Q2 2022, down 17% quarter-over-quarter.
- 2 funds opened new Ultralife positions in Q2 2022 and 2 closed out, a net change of 0 holders.
- The largest Ultralife buyer in Q2 2022 was Janney Montgomery Scott, an estimated $127K added.
- The largest Ultralife seller in Q2 2022 was Morgan Stanley, an estimated $473K sold.
Based on aggregated 13F filings for Q2 2022.